The systemic inflammatory response in coronary artery bypass grafting: What is the role of the very low ejection fraction (EF≤30%)?

Journal of Cardiovascular Surgery

Volumn 49, Issue 6, 2008, Pages 801-808

  Karfis, E A ^a,b,e   Papadopoulos, G ^a   Matsagas, M ^a   Pantazi, D ^c   Lekka, M ^c   Kitsiouli, I ^c   Siminelakis, S ^a   Anagnostopoulos, C ^d   Drossos, G ^b  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b G PAPANICOLAOU HOSPITAL   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

^d New York Presbyterian Columbia University Medical Center   (United States)

^e NONE   (Greece)

Author keywords

Coronary artery bypass; Cytokines; Tumor necrosis factor alpha

Indexed keywords

APROTININ; HEPARIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PROTAMINE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANESTHESIA INDUCTION; ANTICOAGULATION; ARTICLE; BLOOD AUTOTRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CYTOKINE PRODUCTION; EXTRACORPOREAL CIRCULATION; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; STERNOTOMY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; STROKE VOLUME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 59849089439     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery. Implications for the anesthesiologist. Anesthesiology 2002;97:215-52.
2. Wan S, LeClerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies Chest 1997;112:676-92.
3. Elgebaly SA, Houser SL, El Kerm AF, Doyle K, Gillies C, Dalecki K. Evidence of cardiac inflammation after open heart operations. Ann Thorac Surg 1994;57:391-6.
4. Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996;61:1714-20.
5. Prondzinsky R, Knüpfer A, Loppnow H, Redling F, Lehmann DW, Stabenow I et al. Surgical trauma affects the proinflammatory stares after cardiac surgery to a higher degree than cardiopulmonary bypass. J Thorac Cardiovasc Surg 2005;129:760-6.
6. Asimakopoulos G. Mechanisms of the systemic inflammatory response. Perfusion 1999;14:269-77.
7. Raja SG, Dreyfus GD. Modulation of systemic inflammatory response after cardiac surgery. Asian Cardiovasc Thorac Ann 2005;13:382-95.
8. Hennein HA, Ebba H, Rodriguez JL, Merrick SH, Keith FM, Bronstein MH et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization J Thorac Cardiovasc Surg 1994;108:626-35.
9. Billiau A, Vandekerchofe F. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Invest 1991;21:559-73.
10. Halter J, Steinberg J, Fink G, Lutz C, Picone A, Maybury R et al. Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypass. J Extra Corpor Technol 2005;37:272-7.
11. Wan S, DeSmet JM, Barvais L, Golstein M, Vincent JL, LeClerc JL. The myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996;112:806-11.
12. Wan S, LeClerc JL, Vincent JL. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg 1997;63:269-76.
13. Burns SA, Newburger JW, Xiao M, Mayer JE Jr, Walsh AZ, Neufeld EJ. Induction of Interleukin-8 mRNA in heart and skeletal muscle during pediatric cardiopulmonary bypass. Circulation 1995;92(II):315-21.
14. te Velthuis H, Jansen PG, Oudemans-van Straaten HM, Sturrk A, Eijsman L, Wildevuur CR. Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor. J Thorac Cardiovasc Surg 1995;110:1663-69.
15. Wan S, LeClerc JL, Schmartz D, Barvais L, Huynh CH, Deviere J et al. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. Am Heart J 1997;133:335-9.
16. Elefteriades JA, Morales D, Gradel C, Tollis G Jr, Levi E, Zaret BL. Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fraction < 30%. Am J Cardiol 1997;79:1573-8.
17. Nicolini F, Carcagni A, Citterio E, Franciosi G, Gastaldi D, Longo M et al. Myocardial revascularization in patients with severely depressed left ventricular function. Cardiologia 1999;44:535-41.
18. Sadeghi N, Sadeghi S, Mood ZA, Karimi A. Determinants of operative mortality following primary coronary artery bypass surgery. Eur J Cardiothorac Surg 2002;21:187-92.
19. Deng MC, Dasch B, Erren M, Mollhoff T, Scheld HH. Impact of left ventricular dysfunction on cytokines hemodynamics and outcome in bypass grafting. Ann Thorac Surg 1996;62:184-90.
20. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-41.
21. Boglioni FV, Metra M, Locati M, Nodari S, Bontempi L, Gardellini M et al. Role of inflammation mediators in the pathogenesis of heart failure. Ital Heart J 2001;2(6 Suppl):628-33.
22. Rumalla VK, Calvano SE, Spotnitz AJ, Krause TJ, Hilkert RJ, Lin E et al. Alterations in immunocyte tumor necrosis factor receptor and apoptosis in patients with congestive heart failure. Ann Surg 2002;236(2):254-60.
23. Oral H, Kapadia S, Nakano M, Torre-Amione G, Lee J, Lee-Jackson D et al. Tumor necrosis factor alpha and the failing human heart. Clin Cardiol 1995;18(9 suppl):IV20-27.
24. Wan S, Marchant A, Desmet JM, Antoine M, Zhang H, Vachiery JL et al. Human cytokines responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996;111;469-77.
25. Le Moine O, Marchant A, Durand F, Ickx B, Pradier O, Belghiti J et al. Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology 1994;20:889-92.
26. Wei M, Kuukasjarvi P, Laurikka J, Pehkonen E, Kaukinen S, Laine S et al. Cytokine responses in patients undergoing coronaw artery bypass surgery after ischemic preconditioning. Scand Cardiovasc J 2001;35:142-6.
27. Zahler S, Massoudy P, Hartl H, Hahnel C, Meisner H, Becker BF. Acute cardiac inflammatory response to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc Res 1999;41:722-30.
28. Massoudy P, Zahler S, Becker B, Braun SL, Barankay A, Meisner H. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest 2001;119:31-(9.
29. Neumann FJ, Otti I, Gawaz M, Richardt G, Holzapfel H, Jochum M et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995;92:748-55.
30. Ivey CL, Williams FM, Collins PD, Jose PJ, Williams TJ. Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit: evidence for a role of C5a and interleukin 8. J Clin Invest 1995;95:2720-8.
31. Kukielka GL, Smith CW, LaRosa GJ, Manning AM, Mendoza LH, Daly TJ et al. Interleukin-8 gene production in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 1995;95:89-103.
32. Inaba H, Kochi A, Yorozou S. Suppression by methylprednizolone of augmented plasma endotoxin-like activity and interleukin-6 during cardiopulmonary bypass. Br J Anaesth 1994;72:348-50.
33. Nathan N, Preux PM, Feiss P, Denizot Y. Plasma Interleukin-4, Interleukin-10, Interleukin-13 concentrations and complications after coronary artery bypass graft surgery. J Cardiothorac Vasc Anaesth 2000;14:156-60.
34. Wan S, Yim APC. Cytokines in myocardial injury: impact on cardiac surgical approach. Eur J Cardiothorac Surg 1999;16:S107-S111.
35. Butler J, Chong GL, Baigrie RJ, Pillai R, Westaby S, Rocker GM. Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 1992;53:833-8.
36. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106:1008-16.
37. Ohkawa F, Ikeda U, Kanbe T, Kawasaki K, Shimada K. Effects of inflammatory cytokines on vascular tone. Cardiovasc Res 1995;30:711-5.
38. Menasche P, Haydar S, Peynet J, Du Buit C, Merval R, Bloch G et al. A potential mechanism of vasodilation after warm heart surgery: the temperature-dependent release of cytokines. J Thorac Cardiovasc Surg 1994;107:293-9.
39. Massoudy P, Zahler S, Becket BF, Braun SL, Barankay A, Richter JA et al. Significant leukocyte and platelet retention during pulmonary passage after declamping of the aorta in CABG patients. Eur J Med Res 1999;4:178-82.
40. Tassani P, Richter J, Barankay A, Braun SL, Haehnel C, Spaeth P et al. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during CABG procedures. J Cardiothorac Vasc Anesth 1999;13:165-72.